PortfoliosLab logoPortfoliosLab logo
PEN vs. LLY
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PEN vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Penumbra, Inc. (PEN) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PEN achieves a 2.72% return, which is significantly higher than LLY's 0.72% return. Over the past 10 years, PEN has underperformed LLY with an annualized return of 19.12%, while LLY has yielded a comparatively higher 32.66% annualized return.


PEN

1D
0.20%
1M
-1.63%
YTD
2.72%
6M
11.78%
1Y
24.09%
3Y*
-0.16%
5Y*
3.44%
10Y*
19.12%

LLY

1D
1.37%
1M
11.64%
YTD
0.72%
6M
4.73%
1Y
44.70%
3Y*
35.56%
5Y*
41.13%
10Y*
32.66%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PEN vs. LLY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
PEN
Penumbra, Inc.
2.72%30.92%-5.59%13.07%-22.57%64.18%6.53%34.43%29.86%47.49%
LLY
Eli Lilly and Company
0.72%40.25%33.30%60.91%34.26%66.08%31.04%16.14%40.45%17.83%

Correlation

The correlation between PEN and LLY is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.13

Correlation (3Y)
Calculated over the trailing 3-year period

0.15

Correlation (5Y)
Calculated over the trailing 5-year period

0.18

Correlation (10Y)
Calculated over the trailing 10-year period

0.19

Correlation (All Time)
Calculated using the full available price history since Sep 21, 2015

0.18

Fundamentals

Market Cap

PEN:

$12.63B

LLY:

$966.48B

EPS

PEN:

$4.34

LLY:

$28.14

PE Ratio

PEN:

73.51

LLY:

38.33

PEG Ratio

PEN:

0.11

LLY:

0.77

PS Ratio

PEN:

8.65

LLY:

13.41

PB Ratio

PEN:

8.57

LLY:

30.98

Total Revenue (TTM)

PEN:

$1.45B

LLY:

$72.25B

Gross Profit (TTM)

PEN:

$979.97M

LLY:

$59.75B

EBITDA (TTM)

PEN:

$212.61M

LLY:

$32.97B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PEN vs. LLY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PEN
PEN Risk / Return Rank: 6666
Overall Rank
PEN Sharpe Ratio Rank: 6464
Sharpe Ratio Rank
PEN Sortino Ratio Rank: 6767
Sortino Ratio Rank
PEN Omega Ratio Rank: 6868
Omega Ratio Rank
PEN Calmar Ratio Rank: 6464
Calmar Ratio Rank
PEN Martin Ratio Rank: 6767
Martin Ratio Rank

LLY
LLY Risk / Return Rank: 7272
Overall Rank
LLY Sharpe Ratio Rank: 7575
Sharpe Ratio Rank
LLY Sortino Ratio Rank: 7070
Sortino Ratio Rank
LLY Omega Ratio Rank: 7171
Omega Ratio Rank
LLY Calmar Ratio Rank: 7373
Calmar Ratio Rank
LLY Martin Ratio Rank: 7474
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PEN vs. LLY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Penumbra, Inc. (PEN) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PENLLYDifference
Sharpe ratioReturn per unit of total volatility

-0.47

Sortino ratioReturn per unit of downside risk

-0.12

Omega ratioGain probability vs. loss probability

1.21

1.24

-0.02

Calmar ratioReturn relative to maximum drawdown

1.13

1.90

-0.77

Martin ratioReturn relative to average drawdown

3.15

4.73

-1.57

PEN vs. LLY - Sharpe Ratio Comparison

The current PEN Sharpe Ratio is 0.72, which is lower than the LLY Sharpe Ratio of 1.19. The chart below compares the historical Sharpe Ratios of PEN and LLY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


PENLLYDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.72

1.19

-0.47

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.08

1.26

-1.18

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.46

1.09

-0.62

Sharpe Ratio (All Time)

Calculated using the full available price history

0.50

0.57

-0.07

Drawdowns

PEN vs. LLY - Drawdown Comparison

The maximum PEN drawdown since its inception was -62.64%, smaller than the maximum LLY drawdown of -68.24%. Use the drawdown chart below to compare losses from any high point for PEN and LLY.


Loading charts...

Drawdown Indicators


PENLLYDifference

Max Drawdown

Largest peak-to-trough decline

-62.64%

-68.24%

+5.60%

Max Drawdown (1Y)

Largest decline over 1 year

-21.44%

-23.64%

+2.20%

Max Drawdown (3Y)

Largest decline over 3 years

-52.44%

-34.48%

-17.96%

Max Drawdown (5Y)

Largest decline over 5 years

-60.14%

-34.48%

-25.66%

Max Drawdown (10Y)

Largest decline over 10 years

-62.64%

-34.48%

-28.16%

Current Drawdown

Current decline from peak

-11.14%

-4.26%

-6.88%

Average Drawdown

Average peak-to-trough decline

-17.59%

-19.22%

+1.63%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.66%

9.49%

-1.83%

Volatility

PEN vs. LLY - Volatility Comparison

The current volatility for Penumbra, Inc. (PEN) is 3.03%, while Eli Lilly and Company (LLY) has a volatility of 9.16%. This indicates that PEN experiences smaller price fluctuations and is considered to be less risky than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PENLLYDifference

Volatility (1M)

Calculated over the trailing 1-month period

3.03%

9.16%

-6.13%

Volatility (6M)

Calculated over the trailing 6-month period

17.72%

26.81%

-9.09%

Volatility (1Y)

Calculated over the trailing 1-year period

33.61%

37.88%

-4.27%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

41.18%

32.79%

+8.39%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

41.48%

30.14%

+11.34%

Dividends

PEN vs. LLY - Dividend Comparison

PEN has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.60%.


PositionTTM20252024202320222021202020192018201720162015
LLY
Eli Lilly and Company
0.60%0.56%0.67%0.78%1.07%1.23%1.75%1.96%1.94%2.46%2.77%2.37%
PEN
Penumbra, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

PEN vs. LLY - Financials Comparison

This section allows you to compare key financial metrics between Penumbra, Inc. and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00B20222023202420252026
374.76M
19.80B
(PEN) Total Revenue
(LLY) Total Revenue
Values in USD except per share items

PEN vs. LLY - Profitability Comparison

The chart below illustrates the profitability comparison between Penumbra, Inc. and Eli Lilly and Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

50.0%60.0%70.0%80.0%90.0%20222023202420252026
67.6%
79.0%
Portfolio components
PEN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Penumbra, Inc. reported a gross profit of 253.41M and revenue of 374.76M. Therefore, the gross margin over that period was 67.6%.

LLY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a gross profit of 15.64B and revenue of 19.80B. Therefore, the gross margin over that period was 79.0%.

PEN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Penumbra, Inc. reported an operating income of 38.23M and revenue of 374.76M, resulting in an operating margin of 10.2%.

LLY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported an operating income of 9.19B and revenue of 19.80B, resulting in an operating margin of 46.4%.

PEN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Penumbra, Inc. reported a net income of 32.58M and revenue of 374.76M, resulting in a net margin of 8.7%.

LLY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a net income of 7.40B and revenue of 19.80B, resulting in a net margin of 37.4%.


Frequently Asked Questions


PEN and LLY have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

LLY has higher volatility (9.16%) compared to PEN (3.03%). In terms of maximum drawdown, PEN dropped -62.64% vs LLY's -68.24%.

LLY currently has the higher Sharpe Ratio (1.19 vs 0.72), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PEN and LLY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer